Physician profile
John Chipko
NPI 1548553456
$956.50
in general payments reported to CMS, 2019-2025
10 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.20 · 2022: $213 · 2023: $317 · 2024: $204 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $256.32 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| W. L. Gore & Associates, INC. | $166.07 | 2022 | |
| Innovation Technologies INC | $138.98 | 2023-2024 | Irrisept |
| Polynovo North America LLC | $117.18 | 2024 | Novosorb Btm |
| Palette Life Sciences, INC. | $92.86 | 2022-2023 | |
| Argentum Medical | $73.89 | 2023 | |
| Acera Surgical, INC. | $49.23 | 2023-2024 | Restrata Wound Matrix |
| Teleflex LLC | $35.92 | 2025 | Quikclot |
| Haemonetics Corporation | $19.80 | 2024 | Teg6s Hemostasis System |
| Kls-Martin L.P. | $6.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chipko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.